ARCHIVES

Low Adiponcetin Hormone Levels Linked to Increased Cancer Risk

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

News Analysis: Generic Drug Industry’s Efforts to Eliminate Shortages Raises Antitrust Law Questions

April 27, 2012

Gleevec First Pediatric Cancer Approval By FDA In 13 Years

May 30, 2003

NCI To Sponsor Its Own Predoctoral Training At Some Institutions With Postdoctoral Awards

January 31, 1975

NCI Review Groups Merged Into One Umbrella Group

November 17, 1995

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

December 14, 2001

Milken Calls For Renewed War On Cancer, $20 Billion A Year International Effort

November 24, 1995